The “Great Obstetrical Syndromes” are associated with disorders of deep placentation

I Brosens, R Pijnenborg, L Vercruysse… - American journal of …, 2011 - Elsevier
Defective deep placentation has been associated with a spectrum of complications of
pregnancy including preeclampsia, intrauterine growth restriction, preterm labor, preterm …

[HTML][HTML] Potential markers of preeclampsia–a review

S Grill, C Rusterholz, R Zanetti-Dällenbach… - Reproductive biology …, 2009 - Springer
Preeclampsia is a leading cause of maternal and fetal/neonatal mortality and morbidity
worldwide. The early identification of patients with an increased risk for preeclampsia is …

The vascular endothelial growth factor family in adverse pregnancy outcomes

PH Andraweera, GA Dekker… - Human reproduction …, 2012 - academic.oup.com
BACKGROUND Pre-eclampsia, small-for-gestational-age infants, preterm birth and
recurrent miscarriage complicate a significant number of pregnancies. The vascular …

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the …

O Erez, R Romero, J Espinoza, W Fu… - The Journal of …, 2008 - Taylor & Francis
Introduction. An imbalance between angiogenic and anti-angiogenic factors has been
proposed as central to the pathophysiology of preeclampsia (PE). Indeed, patients with PE …

[HTML][HTML] The great obstetrical syndromes

GC Di Renzo - The Journal of Maternal-Fetal & Neonatal Medicine, 2009 - Taylor & Francis
The Journal of Maternal–Fetal and Neonatal Medicine was born when two biomedical
journals merged: The Journal of Maternal–Fetal Medicine and Prenatal and Neonatal …

Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and …

T Chaiworapongsa, R Romero, SJ Korzeniewski… - American journal of …, 2013 - Elsevier
OBJECTIVE: To determine whether maternal plasma concentrations of placental growth
factor (PlGF), soluble endoglin (sEng), and soluble vascular endothelial growth factor …

Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions …

SJ Korzeniewski, R Romero, T Chaiworapongsa… - American journal of …, 2016 - Elsevier
Background Placental lesions consistent with maternal vascular underperfusion (MVU) are
thought to be pathogenically linked to preeclampsia, small-for-gestational-age newborns …

[HTML][HTML] Role of extracellular vesicles and microRNAs on dysfunctional angiogenesis during preeclamptic pregnancies

CA Escudero, K Herlitz, F Troncoso, J Acurio… - Frontiers in …, 2016 - frontiersin.org
Preeclampsia is a syndrome characterized by hypertension during pregnancy, which is a
leading cause of morbidity and mortality in both mother and newborn in developing …

The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia

T Chaiworapongsa, R Romero, AE Whitten… - The Journal of …, 2016 - Taylor & Francis
Abstract Objective: To determine (1) whether maternal plasma concentrations of angiogenic
and anti-angiogenic factors can predict which mothers diagnosed with “suspected small for …

Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study

AL Tarca, A Taran, R Romero, E Jung… - American journal of …, 2022 - Elsevier
Background The current approach to predict preeclampsia combines maternal risk factors
and evidence from biophysical markers (mean arterial pressure, Doppler velocimetry of the …